Paper8317305
Eicosanoid production by the mucosa in inflammatory bowel disease after 5-ASA treatment.
Zijlstra FJ and 4 others. Agents Actions, 1993. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Eicosanoid production by the mucosa in inflammatory bowel disease after 5-ASA treatment. Papers, record 8317305. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8317305
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminosalicylic Acids | Major topic |
| Colitis, Ulcerative | Major topic |
| Eicosanoids | Major topic |
| Intestinal Mucosa | Major topic |
| Female | |
| Humans | |
| Hydroxyeicosatetraenoic Acids | |
| Leukotrienes | |
| Male | |
| Mesalamine | |
| Prostaglandins |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30669 | Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. | Gastroenterology | 1978 | https://conductscience.org/library/papers/30669 | PubMed |
| 2 | 1442336 | 15-HETE is the main eicosanoid formed by human colonic mucosa. | Agents Actions | 1992 | https://conductscience.org/library/papers/1442336 | PubMed |
| 3 | 2535830 | Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. | Gastroenterology | 1989 | https://conductscience.org/library/papers/2535830 | PubMed |
| 4 | 18475455 | Mechanism of action of 5-arninosalicylic acid. | Mediators Inflamm | 1992 | https://conductscience.org/library/papers/18475455 | PubMed |
| 5 | 1969061 | Selective 5-lipoxygenase inhibition in ulcerative colitis. | Lancet | 1990 | https://conductscience.org/library/papers/1969061 | PubMed |
| 6 | 3917261 | Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. | Gastroenterology | 1985 | https://conductscience.org/library/papers/3917261 | PubMed |
| 7 | 53480 | Letter: Prostaglandins, ulcerative colitis, and sulphasalazine. | Lancet | 1975 | https://conductscience.org/library/papers/53480 | PubMed |
| 8 | 2572437 | Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products. | Eur J Pharmacol | 1989 | https://conductscience.org/library/papers/2572437 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22149144 | Effect of fish oil on levels of R- and S-enantiomers of 5-, 12-, and 15-hydroxyeicosatetraenoic acids in mouse colonic mucosa. | Nutr Cancer | 2012 | https://conductscience.org/library/papers/22149144 | PubMed |
| 21937210 | Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice. | J Nutr Biochem | 2012 | https://conductscience.org/library/papers/21937210 | PubMed |
| 12395896 | Intestinal blood flow in murine colitis induced with dextran sulfate sodium. | Dig Dis Sci | 2002 | https://conductscience.org/library/papers/12395896 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8317305
GET https://conductscience.org/api/papers/v1/8317305/authors